NCT02650986 2025-06-17
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
Roswell Park Cancer Institute
Phase 1/2 Active not recruiting
Roswell Park Cancer Institute
Gem Pharmaceuticals
H. Lee Moffitt Cancer Center and Research Institute
GE Healthcare